Search Results

Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management on-demand learning to fit your schedule 🚀 Elevate your expertise today: Start learning now #GPCR #Pharmacology Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management on-demand learning to fit your schedule 🚀 Elevate your expertise today: Start learning now #GPCR #Pharmacology

In Terry’s Corner latest lesson, discover how pharmacologic models do just that. www.ecosystem.drgpcr.com/post/what-if-you-could-predict-drug-behavior-with-just-a-snapshot #GPCR #DrGPCR #pharmacology

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery Published on March 8, 2025 Category Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery Previous Next Recent Articles Why

Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab research awards, including the William James Psychology Award, the Hank Yamamura Endowed Fellowship in Pharmacology She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

Home Courses Articles About Log In / Sign Up Terry's Pharmacology Corner Lost in GPCR Complexity? Fluff, Learn What Matters Join Monthly AMAs with Terry Unlock 40+ Years of Expertise Master GPCRs with Precision Terry’s Pharmacology Corner — Created by Dr. Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge Expert-Level Mastery — Advanced Pharmacology Live AMA Sessions with Terry

more than 25 years of experience in drug development. have been engaged in GPCR cellular and clinical pharmacology I have participated and initiated methodologies for development of pharmacologically active anti-GPCR have published or contributed in 38 published scientific work mainly in the field of immunology and pharmacology

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug Discovery. In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology

Philip Seeman in the Department of Pharmacology at the University of Toronto. His training has provided a strong foundation and appreciation for the applications of pharmacology, Professor Sunahara started his independent research career in the Department of Pharmacology at the University In 2015 Professor Sunahara moved his laboratory to the Department of Pharmacology at the University of The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G

graduate research on the regulation of axonal transport by tricyclic antidepressants (M.Sc.) and molecular pharmacology of opioid receptors (Ph.D.) in the Department of Pharmacology at the Université de Montréal under the The Tiberi Lab pursues the study of the molecular, structural, pharmacological and signaling features

out his Ph.D. at King’s College London, supported by an AJ Clark Ph.D. studentship from the British Pharmacological as Chief Scientific Officer, a contract research organization specializing in molecular and cellular pharmacology several pre-clinical drug discovery projects for both GPCR and non-GPCR targets, using its expertise in pharmacology

Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT)

Join Terry’s Corner and master irreversible pharmacology for modern discovery programs. Unlike reversible ligands, their impact can persist long after the compound is gone — creating durable pharmacological Those who master kinetic pharmacology set the pace. 🟢 Join Terry’s Corner and sharpen your pharmacology GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #MedicinalChemistry #PKPD #ReceptorKinetics

Adriano received his Bachelor of Science degree in Pharmacology in 1991 from the University of Toronto his graduate studies at the University of Toronto where he earned his MSc (1994) and Ph.D. (1998) in Pharmacology In 2004 Adriano joined the faculty of the Department of Pharmacology at Loyola University Chicago.

Pfleger trained as a pharmacologist and obtained his Ph.D. at the University of Edinburgh. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

postdoctoral fellow at the University of Michigan, joins the conversation as a rising voice in GPCR pharmacology GPCRs and the Opioid Crisis: A New Pharmacological Frontier Now at the University of Michigan, Ben focuses Scientific Rigor: The Value of ‘Old School’ Pharmacology Despite the availability of modern tools, Ben Using site-directed mutagenesis and pharmacological synergy assays , his team aims to understand how This project involves molecular pharmacology in cell models to determine binding sites and mechanisms

Summary made with AI About Dmitry Veprintsev Dmitry is Professor of Molecular and Cellular Pharmacology Receptors (COMPARE), University of Nottingham, where he provides leadership in structural and biophysical pharmacology at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural pharmacology In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision pharmacology services.

Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine. studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge of GPCRs pharmacology discovery and adopt data science methodology to tackle relevant scientific questions on the systems pharmacology

Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute of Pharmacology He received a Ph.D. in pharmacology in 1992 from the Russian Academy of Medical Sciences and an M.D. Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology

Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro Pharmacology

Welcome to Flash News—your fastest track to the latest updates in GPCR research, pharmacology, and biotechnology From reluctant intern to scientific leader From local signaling to spatial pharmacology From spark to Terry’s Corner was built to make advanced pharmacology practical: a space where scientists don’t just #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment October 27, 2025 Terry's Corner Read full article Receptor pharmacology has evolved.

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. He was the 2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological

Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging

Soon About Louis Gendron "Dr Louis Gendron, PhD is tenured Professor and Chair of the Department of Pharmacology-Physiology He has 20+ years of experience in in vitro and in vivo GPCR pharmacology and has published seminal papers

papers on lipid-rich domains and GPCR–G protein compartmentalization reframed her view of receptor pharmacology papers on lipid-rich domains and GPCR–G protein compartmentalization reframed her view of receptor pharmacology

elegant mechanistic biology with translational impact — giving us new ways to think about receptor pharmacology , biased agonism, and therapeutic precision. 🔗 Listen here → https://www.ecosystem.drgpcr.com/dr-gpcr-podcast GPCR Premium → https://www.ecosystem.drgpcr.com/gpcr-university #GPCR #DrGPCR #pharmacology #drugdiscovery

Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK.

Pharmacology moves fast. Adaptive thinking—not just tools—keeps you in the game. In our AMA, Terry Kenakin shared timeless career advice for young pharmacologists navigating a fast-changing www.ecosystem.drgpcr.com/terry-corner ✳️ Next AMA Session: ⚠️ Today, Oct 30 | 12–1 PM EST #GPCR #DrGPCR #Pharmacology